Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,845 | 2 | 86.2% |
| Unspecified | $856.82 | 1 | 12.6% |
| Travel and Lodging | $50.70 | 2 | 0.7% |
| Food and Beverage | $31.19 | 2 | 0.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EISAI INC. | $3,050 | 1 | $0 (2018) |
| Johnson & Johnson Health Care Systems Inc. | $2,795 | 1 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $856.82 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $34.95 | 2 | $0 (2019) |
| Amgen Inc. | $32.27 | 1 | $0 (2017) |
| Siemens Medical Solutions USA, Inc. | $14.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,810 | 2 | Johnson & Johnson Health Care Systems Inc. ($2,795) |
| 2019 | $16.52 | 1 | E.R. Squibb & Sons, L.L.C. ($16.52) |
| 2018 | $3,907 | 2 | EISAI INC. ($3,050) |
| 2017 | $50.70 | 2 | Amgen Inc. ($32.27) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $14.67 | General |
| 03/19/2024 | Johnson & Johnson Health Care Systems Inc. | — | Consulting Fee | Cash or cash equivalent | $2,795.00 | General |
| 10/11/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| 12/31/2018 | EISAI INC. | Belviq (Drug) | Consulting Fee | Cash or cash equivalent | $3,050.00 | General |
| Category: Nutrition and Weight Loss | ||||||
| 03/13/2018 | NOVARTIS PHARMACEUTICALS CORPORATION | TAFINLAR (Drug) | — | In-kind items and services | $856.82 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY | ||||||
| 05/16/2017 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $18.43 | General |
| 05/14/2017 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $32.27 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $856.82 | 1 |
About Dr. Andrew Norden, MD
Dr. Andrew Norden, MD is a Neurology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497737456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Norden, MD has received a total of $6,784 in payments from pharmaceutical and medical device companies, with $2,810 received in 2024. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($5,845).
Practice Information
- Specialty Neurology
- Location Boston, MA
- Active Since 11/16/2005
- Last Updated 10/23/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1497737456
Products in Payments
- Belviq (Drug) $3,050
- TAFINLAR (Drug) $856.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Boston
Christopher Wright, Md, MD
Neurology — Payments: $2.0M
Dr. Alfred Sandrock, Md Phd, MD PHD
Neurology — Payments: $1.2M
Thomas Scammell, M.d, M.D
Neurology — Payments: $598,925
Patrick Wen, Md, MD
Neurology — Payments: $583,963
Dr. Michael Levy, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $519,354
Roy Freeman, M.d, M.D
Neurology — Payments: $489,143